|
[1]
|
Cooke GS, Flower B, Cunningham E, Marshall AD, Lazarus JV, Palayew A, et al. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Lancet Gastroenterol Hepatol 2024;9(4):346 − 5. |
|
[2]
|
World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. 2024. https://www.who.int/publications-detail-redirect/9789240090903. [2025-3-17]. |
|
[3]
|
World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. 2016. https://iris.who.int/handle/10665/246177. [2025-3-17]. |
|
[4]
|
World Health Organization. Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. 2020. https://www.who.int/europe/publications/i/item/9789289054782. [2025-3-17]. |
|
[5]
|
Tran L, Cowie BC. Universal testing for hepatitis B must be accompanied by better linkage with care. Med J Aust 2023;218(4):165 − 6. |
|
[6]
|
World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. 2024. https://www.who.int/publications-detail-redirect/9789240091672. [2025-3-17]. |
|
[7]
|
Zheng H, Wang Y, Wang FZ, Shen LP, Zhang GM, Liu JH, et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg Health West Pac 2024;51:101193. |
|
[8]
|
Lim YS, Kim WR, Dieterich D, Kao JH, Flaherty JF, Yee LJ, et al. Evidence for benefits of early treatment initiation for chronic hepatitis B. Viruses 2023;15(4):997. |
|
[9]
|
Chen W, Howell M, Cass A, Gorham G, Howard K. Understanding modelled economic evaluations: a reader's guide for clinicians. Med J Aust 2024;221(6):302 − 7. |
|
[10]
|
Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ 2015;93(2):118 − 24. |
|
[11]
|
World Health Organization. Guidelines on hepatitis B and C testing. 2017. https://www.who.int/publications-detail-redirect/9789241549981. [2025-3-17]. |
|
[12]
|
World Health Organization. Priorities in planning person-centred hepatitis B and C testing services: operational guide. 2024. https://www.who.int/publications/i/item/9789240104082. [2025-3-17]. |
|
[13]
|
Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. Cost-effectiveness of hepatitis B virus infection screening and treatment or vaccination in 6 high-risk populations in the United States. Open Forum Infect Dis 2019;6(1):ofy353. |
|
[14]
|
Polaris Observatory Collaborators. HBV progress towards coverage targets. https://cdafound.org/polaris/dashboard. [2025-3-17]. |
|
[15]
|
Su S, Wong WCW, Zou ZR, Cheng DD, Ong JJ, Chan PL, et al. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. Lancet Glob Health 2022;10(2):e278 − 87. |